Company Filing History:
Years Active: 2012-2013
Title: **Innovations by Karl Cummins: Pioneering Sterile Hyaluronic Acid Solutions**
Introduction: Karl Cummins, an inventive mind based in Hilton, New York, has made significant contributions to the field of biomedical solutions through his innovative patents. With two patents to his name, Cummins has focused on improving sterile hyaluronic acid solutions, which have vital applications in the medical world.
Latest Patents: Cummins' latest patents are centered around sterilized aqueous solutions of hyaluronic acid. The first patent describes a solution comprising 0.04% to 0.8% by weight hyaluronic acid with a weight average molecular weight ranging from 0.6 MDa to 3.6 MDa. This solution includes buffer components such as boric acid, sodium borate, and sodium dihydrogen phosphate, and boasts an ionic strength equivalent to sodium chloride concentrations from 4% to 18% by weight. Furthermore, it is designed to maintain a pH ranging from 6.4 to 7.2 and is filtered through a medium with an average pore size of 0.25 µm or less, ensuring a high level of sterility.
His second patent focuses on a process for sterilizing a hyaluronic acid solution, where the aqueous solution is similarly formulated with a weight average molecular weight of 0.6 MDa to 3.6 MDa and a concentration from 0.04% to 0.8% by weight. This solution is heated at temperatures between 40°C to 80°C for at least one hour and filtered through a sterilization filter medium, resulting in a highly sterile high salt solution.
Career Highlights: Karl Cummins currently holds a position at Bausch & Lomb Incorporated, a prominent company known for its advancements in vision care products and ocular health. His work there illustrates the practical application of his patents in the real-world setting of medical advancements.
Collaborations: Among his coworkers, notable collaborators include X Michael Liu and David J Heiler, both of whom contribute their expertise and insight to the development of innovative solutions in the field.
Conclusion: Karl Cummins exemplifies the spirit of innovation in the biotechnology arena with his pioneering work on sterile hyaluronic acid solutions. Through his patents, he not only addresses critical needs in medical applications but also enhances the potential for future advancements in the industry. His dedication and collaborative efforts serve as a testament to the impact of innovative thought in creating effective healthcare solutions.